Search Results

There are 145125 results for: content related to: Local injection of infliximab in symptomatic isolated mucosal lesions: A novel scenario for endoscopic therapy?

  1. You have full text access to this OnlineOpen article
    Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2209–2217, Casper Steenholdt, Magid Al-khalaf, Jørn Brynskov, Klaus Bendtzen, Ole Ø. Thomsen and Mark A. Ainsworth

    Article first published online : 16 FEB 2012, DOI: 10.1002/ibd.22910

  2. You have free access to this content
    Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 985–1002, Charlotte I. de Bie, Johanna C. Escher and Lissy de Ridder

    Article first published online : 20 SEP 2011, DOI: 10.1002/ibd.21871

  3. You have full text access to this OnlineOpen article
    Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1628–1633, Uri Kopylov, Yoav Mazor, Miri Yavzori, Ella Fudim, Lior Katz, Daniel Coscas, Orit Picard, Yehuda Chowers, Rami Eliakim and Shomron Ben-Horin

    Article first published online : 29 OCT 2011, DOI: 10.1002/ibd.21919

  4. Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 12, June 2013, Pages: 1172–1183, C. Steenholdt, Y. Palarasah, K. Bendtzen, A. Teisner, J. Brynskov, B. Teisner and C. H. Nielsen

    Article first published online : 7 MAY 2013, DOI: 10.1111/apt.12330

  5. You have full text access to this OnlineOpen article
    Monitoring functional serum antitumor necrosis factor antibody level in Crohn's disease patients who maintained and those who lost response to anti-TNF

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1898–1904, Akihiro Yamada, Koji Sono, Nobuo Hosoe, Nobuo Takada and Yasuo Suzuki

    Article first published online : 22 MAR 2010, DOI: 10.1002/ibd.21259

  6. Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: A meta-analytic review

    Journal of Surgical Oncology

    Volume 45, Issue 2, October 1990, Pages: 124–130, Dr. Rafael Rosell, Isabel Moreno, José Maestre, Angel Olazabal, Joan Carles, Augustin Barnadas, Albert Abad-Esteve, Nuria Ribelles and Mercedes Canela

    Article first published online : 19 JUL 2006, DOI: 10.1002/jso.2930450213

  7. You have full text access to this OnlineOpen article
    Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 812–817, M. Barreiro-de Acosta, O. García-Bosch, R. Souto, M. Mañosa, J. Miranda, V. García-Sanchez, J. Gordillo, S. Chacon, C. Loras, D. Carpio, N. Maroto, L. Menchén, M. Rojas-Feria, M. Sierra, A. Villoria, I. Marin-Jimenez and on behalf of Grupo joven GETECCU

    Article first published online : 8 AUG 2011, DOI: 10.1002/ibd.21821

  8. You have full text access to this OnlineOpen article
    Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2043–2055, Daniel A. Sussman, Nisa Kubiliun, Parvez M. Mulani, Jingdong Chao, Carol A.T. Gillis, Mei Yang, Mei Lu and Maria T. Abreu

    Article first published online : 12 JAN 2012, DOI: 10.1002/ibd.22873

  9. You have full text access to this OnlineOpen article
    Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1617–1623, Koji Yoshida, Ken Fukunaga, Hiroki Ikeuchi, Koji Kamikozuru, Nobuyuki Hida, Yoshio Ohda, Yoko Yokoyama, Masaki Iimuro, Naohisa Takeda, Kyoichi Kato, Risa Kikuyama, Kazuko Nagase, Kazutoshi Hori, Shiro Nakamura, Hiroto Miwa and Takayuki Matsumoto

    Article first published online : 13 NOV 2011, DOI: 10.1002/ibd.21928

  10. You have free access to this content
    Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 4, April 2010, Pages: 810–816, Daniel M Sinitsky, Daniel A Lemberg, Steven T Leach, Timothy D Bohane, Reuben Jackson and Andrew S Day

    Article first published online : 24 NOV 2009, DOI: 10.1111/j.1440-1746.2009.06195.x

  11. You have full text access to this OnlineOpen article
    Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

    Inflammatory Bowel Diseases

    Volume 17, Issue 10, October 2011, Pages: 2144–2152, Valérie Crombé, Julia Salleron, Guillaume Savoye, Jean-Louis Dupas, Gwénola Vernier-Massouille, Eric Lerebours, Antoine Cortot, Véronique Merle, Francis Vasseur, Dominique Turck, Corinne Gower-Rousseau, Marc Lémann, Jean-Frédéric Colombel and Alain Duhamel

    Article first published online : 1 FEB 2011, DOI: 10.1002/ibd.21615

  12. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 886–891, Shuji Yamamoto, Hiroshi Nakase, Minoru Matsuura, Yusuke Honzawa, Satohiro Masuda, Ken-ichi Inui and Tsutomu Chiba

    Article first published online : 7 DEC 2009, DOI: 10.1111/j.1440-1746.2009.06206.x

  13. You have full text access to this OnlineOpen article
    Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 1, July 2011, Pages: 51–58, C. Steenholdt, M. Svenson, K. Bendtzen, O. Ø. Thomsen, J. Brynskov and M. A. Ainsworth

    Article first published online : 3 MAY 2011, DOI: 10.1111/j.1365-2036.2011.04682.x

  14. You have full text access to this OnlineOpen article
    Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 8, October 2012, Pages: 765–771, N. Vande Casteele, D. J. Buurman, M. G. G. Sturkenboom, J. H. Kleibeuker, S. Vermeire, T. Rispens, D. van der Kleij, A. Gils and G. Dijkstra

    Article first published online : 28 AUG 2012, DOI: 10.1111/apt.12030

  15. You have full text access to this OnlineOpen article
    Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 11-12, December 2005, Pages: 1107–1113, E. DOMÈNECH, J. HINOJOSA, P. NOS, E. GARCIA-PLANELLA, E. CABRÉ, I. BERNAL and M. A. GASSULL

    Article first published online : 2 NOV 2005, DOI: 10.1111/j.1365-2036.2005.02670.x

  16. You have free access to this content
    Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 5, March 2010, Pages: 553–560, Y. ZABANA, E. DOMÈNECH, M. MAÑOSA, E. GARCIA-PLANELLA, I. BERNAL, E. CABRÉ and M. A. GASSULL

    Article first published online : 30 NOV 2009, DOI: 10.1111/j.1365-2036.2009.04206.x

  17. You have full text access to this OnlineOpen article
    Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels

    Clinical & Experimental Immunology

    Volume 172, Issue 1, April 2013, Pages: 54–62, L. Semerano, J. Biton, L. Delavallée, E. Duvallet, E. Assier, N. Bessis, E. Bernier, O. Dhellin, G. Grouard-Vogel and M.-C. Boissier

    Article first published online : 10 MAR 2013, DOI: 10.1111/cei.12040

  18. Drug Interaction Effects on Antitumour Drugs (VIII): Prevention of Ifosfamide-Induced Urotoxicity by Disulfiram and its Effect on Antitumour Activity and Acute Toxicity of Alkylating Agents in Mice

    Pharmacology & Toxicology

    Volume 68, Issue 1, January 1991, Pages: 21–25, Masaaki Ishikawa, Yoshio Takayanagi and Ken-ichi Sasaki

    Article first published online : 25 MAR 2009, DOI: 10.1111/j.1600-0773.1991.tb01202.x

  19. Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 5, September 2013, Pages: 447–459, R. Khanna, B. D. Sattin, W. Afif, E. I. Benchimol, E.-J. Bernard, A. Bitton, B. Bressler, R. N. Fedorak, S. Ghosh, G. R. Greenberg, J. K. Marshall, R. Panaccione, E. G. Seidman, M. S. Silverberg, A. H. Steinhart, R. Sy, G. Van Assche, T. D. Walters, W. J. Sandborn and B. G. Feagan

    Article first published online : 14 JUL 2013, DOI: 10.1111/apt.12407

  20. You have free access to this content
    Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 5, March 2012, Pages: 562–567, E. Rostholder, A. Ahmed, A. S. Cheifetz and A. C Moss

    Article first published online : 13 JAN 2012, DOI: 10.1111/j.1365-2036.2011.04986.x